Curebound adds five business leaders to board to accelerate cancer research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Curebound, a philanthropic organization that funds innovative cancer research and accelerates better prevention, detection, and treatments for cancer, announced the appointment of Gil Alvarado, Bret Gossett, David Hale, Anne Marbarger, and Tim Scott to its board of directors. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login